Skip to content

Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy

Pilot Study of Cough Peak Flow And Airway Clearance in Pediatric Patients With Neuromuscular Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02034305
Enrollment
7
Registered
2014-01-13
Start date
2014-01-31
Completion date
2021-01-01
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy

Keywords

Airway Clearance, Duchenne Muscular Dystrophy, Peak Cough Flow

Brief summary

This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine whether airway clearance is augmented by high frequency chest wall oscillation.

Interventions

None listed

Sponsors

Respirtech, Inc.
CollaboratorINDUSTRY
University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
6 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Age 6-21; able to cooperate with study procedures * Duchenne Muscular Dystrophy OR Becker Muscular Dystrophy

Exclusion criteria

* Need for mechanical ventilation during the day * Recent (within 2 weeks) lower respiratory tract infection

Design outcomes

Primary

MeasureTime frame
Spontaneous cough clearanceAssessed at multiple time points over 30 minutes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026